Recipharm has officially commenced the supply of commercial products to Roche, and has completed the acquisition of a manufacturing facility located in Leganés, Spain.

The facility currently produces solid dose products and is licensed to supply products globally to more than 95 countries.

Thomas Eldered, chief executive officer of Recipharm, said, “We are continuing to gain momentum in the CDMO market and this latest agreement is another demonstration of this. I welcome our new colleagues in Spain and look forward to providing Roche with first-class CDMO services”. 

Recipharm is a CDMO that offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development.